Behavior of X-Ray Analysis of Carbon Nanotubes

Carbon nanotubes with a variety of types occupied an amazing position compared to other nanomaterials due to rarer and specific physical and chemical properties. The behavior of graphite or graphite nanotubes theoretically and experimentally encourages their use in huge applications such as industries, fields of energy, and the environment. Many attempts are being made to get more of these benefits by a better understanding of the nature of carbon nanotubes. One of the ways to achieve this aim is by enhancing the acquaintance of characterization such as spectroscopy analysis and image microscopy. In this chapter, we are concerned with using X-ray as a source to produce clear imaginations for a tubular structure. Thus, the common ways that use X-ray as a source to interact with carbon nanotubes will be reviewed with details of characterization such as XRD, XRF, XPS, and EDX techniques

Structural features discriminating hybrid histidine kinase Rec domains from response regulator homologs

In two-component systems, the information gathered by histidine kinases (HKs) are relayed to cognate response regulators (RRs). Thereby, the phosphoryl group of the auto-phosphorylated HK is transferred to the receiver (Rec) domain of the RR to allosterically activate its effector domain. In contrast, multi-step phosphorelays comprise at least one additional Rec (Rec; inter; ) domain that is typically part of the HK and acts as an intermediary for phosphoryl-shuttling. While RR Rec domains have been studied extensively, little is known about discriminating features of Rec; inter; domains. Here we study the Rec; inter; domain of the hybrid HK CckA by X-ray crystallography and NMR spectroscopy. Strikingly, all active site residues of the canonical Rec-fold are pre-arranged for phosphoryl-binding and BeF; 3; -; binding does not alter secondary or quaternary structure, indicating the absence of allosteric changes, the hallmark of RRs. Based on sequence-covariation and modeling, we analyze the intra-molecular DHp/Rec association in hybrid HKs

New insights into the enzymatic mechanism of human chitotriosidase (CHIT1) catalytic domain by atomic resolution X-ray diffraction and hybrid QM/MM

Chitotriosidase (CHIT1) is a human chitinase belonging to the highly conserved glycosyl hydrolase family 18 (GH18). GH18 enzymes hydrolyze chitin, an N-acetylglucosamine polymer synthesized by lower organisms for structural purposes. Recently, CHIT1 has attracted attention owing to its upregulation in immune-system disorders and as a marker of Gaucher disease. The 39 kDa catalytic domain shows a conserved cluster of three acidic residues, Glu140, Asp138 and Asp136, involved in the hydrolysis reaction. Under an excess concentration of substrate, CHIT1 and other homologues perform an additional activity, transglycosylation. To understand the catalytic mechanism of GH18 chitinases and the dual enzymatic activity, the structure and mechanism of CHIT1 were analyzed in detail. The resolution of the crystals of the catalytic domain was improved from 1.65 Å (PDB entry 1waw ) to 0.95-1.10 Å for the apo and pseudo-apo forms and the complex with chitobiose, allowing the determination of the protonation states within the active site. This information was extended by hybrid quantum mechanics/molecular mechanics (QM/MM) calculations. The results suggest a new mechanism involving changes in the conformation and protonation state of the catalytic triad, as well as a new role for Tyr27, providing new insights into the hydrolysis and transglycosylation activities.Fil: Fadel, Firas. Centre National de la Recherche Scientifique; Francia. Institut de Génétique et de Biologie Moléculaire et Cellulaire; FranciaFil: Zhao, Yuguang. University of Oxford; Reino UnidoFil: Cachau, Raul. Frederick National Laboratory for Cancer Research; Estados UnidosFil: Cousido Siah, Alexandra. Centre National de la Recherche Scientifique; Francia. Institut de Génétique et de Biologie Moléculaire et Cellulaire; FranciaFil: Ruiz, Francesc X.. Centre National de la Recherche Scientifique; Francia. Institut de Génétique et de Biologie Moléculaire et Cellulaire; FranciaFil: Harlos, Karl. University of Oxford; Reino UnidoFil: Howard, Eduardo Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Física de Líquidos y Sistemas Biológicos. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Física de Líquidos y Sistemas Biológicos; Argentina. Centre National de la Recherche Scientifique; Francia. Institut de Génétique et de Biologie Moléculaire et Cellulaire; FranciaFil: Mitschler, Andre. Centre National de la Recherche Scientifique; Francia. Institut de Génétique et de Biologie Moléculaire et Cellulaire; FranciaFil: Podjarny, Alberto Daniel. Centre National de la Recherche Scientifique; Francia. Institut de Génétique et de Biologie Moléculaire et Cellulaire; Franci

New insights into the enzymatic mechanism of human chitotriosidase (CHIT1) catalytic domain by atomic resolution X-ray diffraction and hybrid QM/MM

Chitotriosidase (CHIT1) is a human chitinase belonging to the highly conserved glycosyl hydrolase family 18 (GH18). GH18 enzymes hydrolyze chitin, an N-acetylglucosamine polymer synthesized by lower organisms for structural purposes. Recently, CHIT1 has attracted attention owing to its upregulation in immune-system disorders and as a marker of Gaucher disease. The 39 kDa catalytic domain shows a conserved cluster of three acidic residues, Glu140, Asp138 and Asp136, involved in the hydrolysis reaction. Under an excess concentration of substrate, CHIT1 and other homologues perform an additional activity, transglycosylation. To understand the catalytic mechanism of GH18 chitinases and the dual enzymatic activity, the structure and mechanism of CHIT1 were analyzed in detail. The resolution of the crystals of the catalytic domain was improved from 1.65 Å (PDB entry 1waw ) to 0.95-1.10 Å for the apo and pseudo-apo forms and the complex with chitobiose, allowing the determination of the protonation states within the active site. This information was extended by hybrid quantum mechanics/molecular mechanics (QM/MM) calculations. The results suggest a new mechanism involving changes in the conformation and protonation state of the catalytic triad, as well as a new role for Tyr27, providing new insights into the hydrolysis and transglycosylation activities.Instituto de Física de Líquidos y Sistemas Biológico

Effects of feeding frequencies on the growth, plasma biochemistry, and liver glycogen of jade perch Scortum barcoo in a recirculating system

Jade Perch Scortum barcoo having an initial average weight of 7.28 ± 0.13 g (mean ± SE) were cultured in a recirculating system at different feeding frequencies that included one, two, three, or four meals a day at 5% body weight per day. Treatments were performed in triplicate using 65 fish in each replicate. After 72 d, the survival, growth, feeding efficiencies, body indices, plasma biochemistry, whole-body proximate composition, and muscle cholesterol were measured while histological sections of the liver were stained for glycogen with periodic acid Schiff. Results showed that growth was best when fish were fed three times a day, which was significantly higher than those fed one, two or four times a day. Feeding efficiencies were significantly better for fish fed two or three times a day. Plasma glucose, plasma cholesterol, periodic acid Schiff staining intensity of the liver, and hepatosomatic index were significantly higher for fish fed three times a day compared with once a day. Whole-body crude protein was significantly lower for fish fed once a day compared with treatments of two or four times a day. Muscle cholesterol tended to increase with increasing feeding frequencies, but the results were not significant. No significant treatment effect was detected on the plasma mineral content. Based on a feeding rate of 5% body weight/d, it is recommended that feedings are divided into three meals a day to increase available energy for optimal growth

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

Etude structurale et mécanistique à haute résolution de la chitotriosidase humaine (CHIT1)

La chitotriosidase (CHIT1) est une chitinase humaine appartenant à la famille glycosyl hydrolase 18 (GH18) qui hydrolyse la chitine. CHIT1 présente plusieurs caractéristiques enzymatiques conservées dans la famille GH18 qui ne sont pas complètement comprises. Pour renforcer nos connaissances sur le mécanisme catalytique de CHIT1 et de la famille GH18, j'ai amélioré la résolution des structures obtenues par diffraction de rayon-X du domaine catalytique de CHIT1. Ces structures correspondent à la forme apo de CHIT1, pseudo-apo ainsi qu’en complexe avec la chitobiose ont été obtenues à des résolutions comprises entre 0.95Å et 1.10Å. Mes résultats m’ont permis de proposer un nouveau mécanisme d’hydrolyse des chaines chito-oligosaccharidiques. En outre, grâce à une nouvelle stratégie de cristallisation, la première structure cristalline de CHIT1 complète a pu être obtenue à une résolution de 1.95Å. Mon étude donne de nouvelles perspectives sur le mode d'action de CHIT1 et les caractéristiques enzymatiques conservées dans la famille GH18.Chitotriosidase (CHIT1) is a human chitinase belonging to the glycosyl hydrolase family 18 (GH18), a highly conserved enzyme family. GH18 enzymes hydrolyze chitin, a N-acetyl glucosamine polymer. CHIT1 is characterized by many enzymatic features that are conserved in GH18 and not completely understood. To increase our knowledge on the catalytic mechanism in CHIT1 and GH18 family, I improved the X-ray resolution crystal structure of CHIT1 catalytic domain in apo and pseudo apo forms as well as in complex with a synthetic substrate to a resolution range between 0.95Å and at 1.10Å. My results allow me to suggest a new mechanism for chito-oligosaccharide chains hydrolysis. Moreover, thanks to a new a crystallogenesis strategy, I obtained the first crystal structure of full length CHIT1 at 1.95Å resolution. My study presents many structural and mechanistic aspects of CHIT1 which gives new insights onto its mode of action and shed light into the conserved enzymatic features in GH18 chitinase family

Etude structurale et mécanistique à haute résolution de la chitotriosidase humaine (CHIT1)

La chitotriosidase (CHIT1) est une chitinase humaine appartenant à la famille glycosyl hydrolase 18 (GH18) qui hydrolyse la chitine. CHIT1 présente plusieurs caractéristiques enzymatiques conservées dans la famille GH18 qui ne sont pas complètement comprises. Pour renforcer nos connaissances sur le mécanisme catalytique de CHIT1 et de la famille GH18, j'ai amélioré la résolution des structures obtenues par diffraction de rayon-X du domaine catalytique de CHIT1. Ces structures correspondent à la forme apo de CHIT1, pseudo-apo ainsi qu’en complexe avec la chitobiose ont été obtenues à des résolutions comprises entre 0.95Å et 1.10Å. Mes résultats m’ont permis de proposer un nouveau mécanisme d’hydrolyse des chaines chito-oligosaccharidiques. En outre, grâce à une nouvelle stratégie de cristallisation, la première structure cristalline de CHIT1 complète a pu être obtenue à une résolution de 1.95Å. Mon étude donne de nouvelles perspectives sur le mode d'action de CHIT1 et les caractéristiques enzymatiques conservées dans la famille GH18.Chitotriosidase (CHIT1) is a human chitinase belonging to the glycosyl hydrolase family 18 (GH18), a highly conserved enzyme family. GH18 enzymes hydrolyze chitin, a N-acetyl glucosamine polymer. CHIT1 is characterized by many enzymatic features that are conserved in GH18 and not completely understood. To increase our knowledge on the catalytic mechanism in CHIT1 and GH18 family, I improved the X-ray resolution crystal structure of CHIT1 catalytic domain in apo and pseudo apo forms as well as in complex with a synthetic substrate to a resolution range between 0.95Å and at 1.10Å. My results allow me to suggest a new mechanism for chito-oligosaccharide chains hydrolysis. Moreover, thanks to a new a crystallogenesis strategy, I obtained the first crystal structure of full length CHIT1 at 1.95Å resolution. My study presents many structural and mechanistic aspects of CHIT1 which gives new insights onto its mode of action and shed light into the conserved enzymatic features in GH18 chitinase family

NMR assignments of the GacS histidine-kinase periplasmic detection domain from Pseudomonas aeruginosa PAO1

International audiencePseudomonas aeruginosa is a highly adaptable opportunistic pathogen. It can infect vulnerable patients such as those with cystic fibrosis or hospitalized in intensive care units where it is responsible for both acute and chronic infection. The switch between these infections is controlled by a complex regulatory system involving the central GacS/GacA two-component system that activates the production of two small non-coding RNAs. GacS is a histidine kinase harboring one periplasmic detection domain, two inner-membrane helices and three H1/D1/H2 cytoplasmic domains. By detecting a yet unknown signal, the GacS histidine-kinase periplasmic detection domain (GacSp) is predicted to play a key role in activating the GacS/GacA pathway. Here, we present the chemical shift assignment of 96 % of backbone atoms (HN, N, C, Ca, Cb and Ha), 88 % aliphatic hydrogen atoms and 90 % of aliphatic carbon atoms of this domain. The NMR-chemical shift data, on the basis of Talos server secondary structure predictions, reveal that GacSp consists of 3 b-strands, 3 a-helices and a major loop devoid of secondary structures

Pharmacokinetic evaluation of oral deracoxib in geese (Anser anser domesticus)

: The integration of pain management in veterinary practice, driven by heightened animal welfare concerns, extends to avian species where subtle and nonspecific behavioral signs pose challenges. Given that safety concerns with classical NSAIDs highlight the need for more targeted alternatives in birds, this study explores the pharmacokinetic (PK) properties of Deracoxib (DX), a COX-2 selective NSAID approved for use in dogs, following a single oral administration in geese. Six healthy female geese received 4 mg/kg DX. Blood was drawn from the left wing vein to heparinized tubes at 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 4, 6, 8, 10, and 24 h. Plasma DX concentrations were measured using HPLC coupled to an UV detector, and the data were pharmacokinetically analyzed using PKanalixTM software in a non-compartmental approach. The results indicated a terminal half-life of 6.3 h and a Tmax of 1 h, with no observed adverse effects. While refraining from claiming absolute safety based on a single dose, it is worth highlighting that further safety studies for DX in geese are warranted, suggesting a possibility for intermittent use. In addition, drawing conclusions on efficacy and suitability awaits further research, particularly in understanding COX-2 selectivity and protein binding characteristics specific to geese